McCarthy Tétrault assisted Aptose Biosciences Inc. on the matter. On September 6, 2023, Aptose Biosciences Inc. announced the closing of a US$3 million investment in common shares...
Hanmi Pharmaceutical Inc.’s US$3 Million Private Equity Investment in Aptose Biosciences
Aptose Biosciences Inc.’s Equity Agreement with JonesTrading Institutional Services LLC
McCarthy Tétrault assisted Aptose Biosciences Inc. on the deal. On December 12, 2022, Aptose Biosciences Inc. has entered into an equity distribution agreement with JonesTrading Institutional...
Aptose Biosciences Inc.’s License Agreement with Hanmi Pharmaceutical
McCarthy Tétrault advised Aptose Biosciences on the deal. Aptose Biosciences Inc. has entered into an exclusive license agreement with Hanmi Pharmaceutical to develop and commercialize HM43239. Under the...